Sermorelin has older clinical history tied to its 1997 approval, while ipamorelin remains primarily a preclinical research compound
Clinical evidence of the effect of GLP-1RAs on skeletal muscle mass Clinical effects of GLP-1RAs on body composition and lean body mass Multiple clinical studies have confirmed that glucagon-like peptide-1 receptor agonists have significant effects in reducing overall weight and fat mass
If you have questions about your prescription drug coverage, including quantity limits or prior authorizations, call OptumRx Member Services at (866) 533-6977 or visit While every attempt has been made to ensure the accuracy of this Summary, in the event of any discrepancy the Summary Plan Description and Plan Document will prevail.
Millions of patients have used them to lose significant weight
NICE guidance (NG28) emphasises the importance of continuing lifestyle modifications and other pharmacological treatments to maintain metabolic control
For patients with allergies or sensitivities to certain ingredients in Mounjaro, compounded versions can be formulated to exclude problematic components while maintaining therapeutic efficacy